Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP11B1 | P15538 | 3/20 | 0.36 |
| ▸ | CYP11B2 | P19099 | 3/20 | 0.36 |
| ▸ | HTR2C | P28335 | 2/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.33 |
| ▸ | PIM1 | P11309 | 1/20 | 0.33 |
| ▸ | ALOX5AP | P20292 | 1/20 | 0.32 |
| ▸ | FEN1 | P39748 | 1/20 | 0.32 |
| ▸ | PARP1 | P09874 | 1/20 | 0.32 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.32 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26548699 | 0.90 | TDP1 (0.40) | CYP11B1CYP11B2HPGDTDP1PIM1 | |
| SCHEMBL26567171 | 0.87 | CYP11B1 (0.40) | CYP11B1CYP11B2TDP1ALOX5APFEN1 | |
| SCHEMBL26567383 | 0.86 | TOP1 (0.36) | HTR2CALOX5APFEN1PARP1 | |
| SCHEMBL26553076 | 0.86 | CA12 (0.38) | HTR2CCYP1A2CYP2A6 | |
| SCHEMBL26567691 | 0.86 | ALOX5 (0.35) | CYP11B1CYP11B2 | |
| SCHEMBL26548184 | 0.86 | TDP1 (0.40) | CYP11B1CYP11B2HPGDTDP1PIM1 | |
| SCHEMBL26567180 | 0.84 | CYP11B1 (0.45) | CYP11B1CYP11B2HTR2CPIM1CYP1A2 | |
| SCHEMBL26548696 | 0.84 | TRPV1 (0.40) | CYP11B1CYP11B2HPGDPIM1ALOX5AP | |
| SCHEMBL26567350 | 0.84 | PTGS1 (0.38) | CYP11B1CYP11B2ALOX5APFEN1CYP1A2 | |
| SCHEMBL26567266 | 0.83 | SMN1; SMN2 (0.38) | CYP11B1CYP11B2HPGDALOX5APFEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230337527-A1 | ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME | LAPTO CO., LTD. (KR) | 2023-10-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230337527-A1 | ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME | AOC1, ODC1, PIEZO1 | CYP11B1 1676/4885CYP11B2 1913/4885HTR2C 4038/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.